Access full Report @ World Excipient Market - Opportunities and Forecast, 2014 - 2020
Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use. The world excipient market volume is estimated to reach 728.4 kilo tons by 2020, accounting for a revenue of $6.4 billion.
The world excipients market is driven by the increase in demand for oral solid pharmaceutical drugs and emergence of novel therapeutics on account of the upsurge in the number of pharmaceutical industries. The amalgamation of drug formulation and nanotechnology in pharmaceutical excipients have led to the development of nano-coated tablets, nano-derived liposomes, and vaccines. In addition, several companies have targeted the emerging economies for expansion of their plants for manufacturing pharmaceutical excipients, owing to cost-effective labor. However, higher production cost and stringent government regulations are likely to impede the market growth.
This report segments the world excipient market on the basis of type, function, and geography. Based on type, the market is segmented into organic and inorganic chemicals. Organic chemicals are further categorized into carbohydrates and petrochemicals. Based on function, the world market is classified into fillers and diluents, binders, coatings, flavoring agents, disintegrants, colorants, and others. The market has been analyzed on the basis of regions, namely North America, Europe, Asia-Pacific, and LAMEA. The North American excipient market is the leading revenue-generating region, owing to growing demand for solid oral drugs for the treatment of chronic diseases. However, the Asia-Pacific market is expected to register the highest CAGR, owing to low cost of raw materials and availability of cost-effective workforce.The key companies profiled in this report include Ashland, Inc., BASF SE, Associated British Foods Plc, Akzo Nobel N.V., Evonik, Merck, J.M. Huber Corporation, Dow Chemicals Corporation, Merck Millipore, Croda International, and Archer Daniels Midland. These companies have adopted product launch as their key developmental strategy to expand their market presence.
KEY BENEFITS FOR STAKEHOLDERS:
The world excipient report offers an extensive analysis of the current trends along with the future market scenario across various geographies.
This report provides a detailed quantitative analysis of the current market and estimations from 2014 to 2020 to identify the prevailing market opportunities.
The report provides an in-depth analysis of the key driving and restraining factors of the market.
The key manufacturers of excipient are profiled in this report and comprehensive analysis of their growth strategies is provided to understand the competitive landscape.
This report offers detailed insights on new product launches and research and development activities taking place in the excipients industry.
SWOT analysis highlights the market positioning of leading manufacturers to formulate effective growth strategies.
The world excipient market has been analyzed on the basis of regions to understand the regional trends across various geographies.
Market By Type
Market By Function
Fillers and diluents
Market By Geography
CHAPTER 1 INTRODUCTION
1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology
1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2020
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 US-FDA perspective
3.3.2 EU EMEA perspective
3.3.3 Japan MHW perspective
3.4 Nanotechnology in excipient
3.5 Emerging role of excipient in the pharmaceutical industry
3.6 Porters five force analysis
3.6.1 Limited suppliers increase bargaining power
3.6.2 Lesser bargaining power of buyers due to intense competition
3.6.3 Lesser hazard from substitutes due to high fixed cost
3.6.4 Lesser threats from new entrants due to high capital investment
3.6.5 Superficial competition due to lesser global players
3.7 Value chain analysis
3.8 Patent analysis
3.9 Clinical trials
3.9.1 A study of insulin lispro with biochaperone excipient in healthy participants
3.9.2 Understanding typhoid disease after vaccination
3.9.3 Clinical trial no. 2 effect on acetaminophen metabolism by liquid formulations
3.9.4 Class 3 biowaivers
3.9.5 Phase 1 Norwalk vaccine study
3.10 Market dynamics
18.104.22.168 Positive momentum of pharmaceutical industries
22.214.171.124 Impact of new excipients on the pharmaceutical industry
126.96.36.199 Diversified geographic market that reduces earnings
188.8.131.52 Supply chain issues
184.108.40.206 Segregated excipient market that reduces earnings
220.127.116.11 Higher production cost
18.104.22.168 Stringent government regulations
22.214.171.124 Declining R&D investment
126.96.36.199 Opportunities in developing economies
188.8.131.52 New product development
Purchase a licensed copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=371683
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
P: +44 208 133 9349
M: +1 646 845 9349